Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-06-04 Sale |
2024-06-04 5:31 pm |
Fusion Pharmaceuticals Inc. | FUSN | GANNON STEVEN Director |
56,400 | $0 | $0 | 0 (Direct) |
View |
| 2024-03-07 Sale |
2024-03-08 5:28 pm |
Xenon Pharmaceuticals Inc. | XENE | GANNON STEVEN Director |
13,000 | $46.28 | $601,615 | 2,000 (Direct) |
View |
| 2022-08-11 Purchase |
2022-08-11 4:19 pm |
Fusion Pharmaceuticals Inc. | FUSN | GANNON STEVEN Director |
44,400 | $2.03 | $90,132 | 56,400 (Direct) |
View |
| 2021-08-23 Purchase |
2021-08-23 6:28 pm |
Fusion Pharmaceuticals Inc. | FUSN | GANNON STEVEN Director |
2,829 | $7.985 | $22,590 | 12,000 (Direct) |
View |
| 2021-08-18 Purchase |
2021-08-20 4:10 pm |
Fusion Pharmaceuticals Inc. | FUSN | GANNON STEVEN Director |
3,171 | $8.05 | $25,527 | 9,171 (Direct) |
View |
| 2021-08-16 Purchase |
2021-08-17 4:05 pm |
Fusion Pharmaceuticals Inc. | FUSN | GANNON STEVEN Director |
6,000 | $8.1 | $48,600 | 6,000 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-06-05 Option Award |
2024-06-05 5:42 pm |
N/A 2034-06-04 |
Xenon Pharmaceuticals Inc. | XENE | GANNON STEVEN Director |
15,542 | $0 | 15,542 (Direct) |
View |
| 2023-06-14 Option Award |
2023-06-14 5:07 pm |
N/A 2033-06-13 |
Fusion Pharmaceuticals Inc. | FUSN | GANNON STEVEN Director |
17,000 | $0 | 17,000 (Direct) |
View |
| 2023-06-02 Option Award |
2023-06-02 5:25 pm |
N/A 2033-06-01 |
Xenon Pharmaceuticals Inc. | XENE | GANNON STEVEN Director |
18,475 | $0 | 18,475 (Direct) |
View |
| 2022-06-28 Option Award |
2022-06-29 5:26 pm |
N/A 2032-06-27 |
Xenon Pharmaceuticals Inc. | XENE | GANNON STEVEN Director |
18,000 | $0 | 18,000 (Direct) |
View |
| 2022-06-14 Option Award |
2022-06-22 7:09 pm |
N/A 2032-06-13 |
Fusion Pharmaceuticals Inc. | FUSN | GANNON STEVEN Director |
17,000 | $0 | 17,000 (Direct) |
View |
| 2021-06-04 Option Award |
2021-06-07 4:15 pm |
N/A 2031-06-03 |
Fusion Pharmaceuticals Inc. | FUSN | GANNON STEVEN Director |
17,000 | $0 | 17,000 (Direct) |
View |
| 2021-06-03 Option Award |
2021-06-03 9:04 pm |
N/A 2031-06-02 |
Xenon Pharmaceuticals Inc. | XENE | GANNON STEVEN Director |
10,000 | $0 | 10,000 (Direct) |
View |
| 2020-01-19 Option Award |
2020-06-30 06:49 am |
N/A 2030-01-19 |
Fusion Pharmaceuticals Inc. | FUSN | GANNON STEVEN Director |
171,011 | $0 | 171,011 (Direct) |
View |
Ownership |
2020-06-25 8:02 pm |
N/A 2030-01-19 |
Fusion Pharmaceuticals Inc. | FUSN | GANNON STEVEN Director |
0 | $0 | 141,011 (Direct) |
View |
| 2020-06-01 Option Award |
2020-06-02 5:00 pm |
N/A 2030-05-31 |
Xenon Pharmaceuticals Inc. | XENE | GANNON STEVEN Director |
10,000 | $0 | 10,000 (Direct) |
View |